文献速递腹部介入CT

预测肝细胞癌患者TACE术后生存的参数反应映射截断值

Parametric response mapping cut-off values that predict survival of hepatocellular carcinoma patients after TACE.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

这项探索性单中心研究对20例肿瘤≥2 cm的肝细胞癌患者基线和3次TACE后的双期CT行参数反应映射,发现ROI内富血供组织比例是TACE术后总生存的独立预测因子,1、2、3年生存的截断值分别为3650、2057、2057体素,敏感度80%、92%、86%,特异度60%、75%、83%,AUC 0.73~0.87。

要点

  • 参数反应映射(PRM)基于双期CT体素密度散点图计算肿瘤富血供组织比例。
  • 富血供组织比例是TACE术后总生存的独立预测因子。
  • 预测1、2、3年生存的截断值分别为3650、2057、2057体素。

核心结论

  • PRM可能对预测肝细胞癌患者TACE术后总生存具有预后价值。

研究设计与样本

  • 探索性单中心研究,纳入20例肿瘤≥2 cm的肝细胞癌患者,对基线和3次TACE后的双期CT行PRM分析,以生存状态为参考。

关键影像表现/征象

  • 将门静脉期与动脉期配准后分割最大病灶作为感兴趣区(ROI)。
  • 将分割体素的动脉期和门静脉期密度值绘制为散点图。
  • ROI内富血供组织比例被确定为TACE术后总生存的独立预测因子。

诊断标准与关键数值

  • 预测TACE术后1年总生存的富血供组织比例最佳截断值为3650体素,敏感度80%,特异度60%。
  • 预测TACE术后2年总生存的最佳截断值为2057体素,敏感度92%,特异度75%。
  • 预测TACE术后3年总生存的最佳截断值为2057体素,敏感度86%,特异度83%。
  • 预后准确度AUC范围为0.73至0.87。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Parametric response mapping (PRM) is a novel image-analysis technique applicable to assess tumor viability and predict intrahepatic recurrence of hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE). However, to date, the prognostic value of PRM for prediction of overall survival in HCC patients undergoing TACE is unclear. The objective of this explorative, single-center study was to identify cut-off values for voxel-specific PRM parameters that predict the post TACE overall survival in HCC patients.

METHODS: PRM was applied to biphasic CT data obtained at baseline and following 3 TACE treatments of 20 patients with HCC tumors ≥ 2 cm. The individual portal venous phases were registered to the arterial phases followed by segmentation of the largest lesion, i.e., the region of interest (ROI). Segmented voxels with their respective arterial and portal venous phase density values were displayed as a scatter plot. Voxel-specific PRM parameters were calculated and compared to patients' survival at 1, 2, and 3 years post treatment to identify the maximal predictive parameters.

RESULTS: The hypervascularized tissue portion of the ROI was found to represent an independent predictor of the post TACE overall survival. For this parameter, cut-off values of 3650, 2057, and 2057 voxels, respectively, were determined to be optimal to predict overall survival at 1, 2, and 3 years after TACE. Using these cut points, patients were correctly classified as having died with a sensitivity of 80, 92, and 86% and as still being alive with a specificity of 60, 75, and 83%, respectively. The prognostic accuracy measured by area under the curve (AUC) values ranged from 0.73 to 0.87.

CONCLUSION: PRM may have prognostic value to predict post TACE overall survival in HCC patients.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Nörthen A, Asendorf T, Shin HO, et al. Parametric response mapping cut-off values that predict survival of hepatocellular carcinoma patients after TACE. Abdom Radiol (NY). 2018. PMID: 29680967. doi:10.1007/s00261-018-1610-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。